Philips tops profit estimates, reaches agreement in principle with DOJ on Respironics

By Reuters News

By Lucie Barbier

- Dutch healthcare technology manufacturer Philips PHG.AS beat market expectations for third-quarter core earnings on Tuesday, driven by higher sales and gross margin alongside productivity measures.

Philips, which sells products ranging from toothbrushes to medical imaging systems, reported a 7.2% rise in its adjusted earnings before interest, taxes and amortisation to €569 million ($637 million), exceeding a consensus estimate of €522 million provided on the company's website.

Philips also said its Respironics unit had reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations linked to its global sleep and respiratory-care device recall.

It booked a €288 million provision in the quarter for the proposed DOJ settlement, which remains subject to final documentation and is expected to be paid in the first quarter of 2027. The company did not provide details on whether the agreement would include an admission of wrongdoing.

"We cannot provide details qualitatively at this point in time," CEO Roy Jakobs said in a call with journalists, adding the agreement in principle was reached "in the last few days".

($1 = 0.8937 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.